STOCKHOLDERS DEFICIT |
9 Months Ended |
|---|---|
Sep. 30, 2025 | |
| STOCKHOLDERS DEFICIT | |
| STOCKHOLDERS' DEFICIT | NOTE 8 – STOCKHOLDERS’ DEFICIT
As of September 30, 2025 and December 31, 2024, the Company had 51,783,583 and 200,183 shares of common stock issued and outstanding.
As of September 30, 2025 and December 31, 2024, the Company had 12,003,774 and 9,003,774 shares of Class A preferred stock issued and outstanding, respectively.
As of September 30, 2025 and December 31, 2024, the Company had 3,500,000 and 3,500,000 Class B preferred stock issued and outstanding, respectively.
On January 24, 2025, a shareholder converted 1,000,000 shares of the Company’s Series A Preferred Stock into 50,000,000 shares of Common Stock.
During the nine months ended September 30, 2025, the Company sold 14,590,000 shares of the Company’s Common Stock for $145,900 cash.
On May 19, 2025, the Company entered into an Asset Purchase Agreement pursuant to which the Company acquired various proprietary assets and intellectual property for 5,000,000 restricted shares of common stock valued at $50,000.
On August 7, 2025, a shareholder agreed to return and cancel 20,000,000 shares of common stock for the issuance of 4,000,000 share of Series A Preferred Stock.
On August 12, 2025, the noteholder agreed to settle three notes and accrued interest dated May 4, 2023, June 30, 2023, and August 9, 2023 amounting to $19,934 and $3,165 in accrued interest for 1,993,400 shares valued at $19,934. |